Company Filing History:
Years Active: 2022-2024
Title: John E Kraus: Innovator in Dermatological Treatments
Introduction
John E Kraus is a notable inventor based in Pittsboro, NC (US). He has made significant contributions to the field of dermatology, particularly in the treatment of skin conditions such as atopic dermatitis and plaque psoriasis. With a total of 3 patents to his name, Kraus continues to push the boundaries of innovation in topical treatments.
Latest Patents
Kraus's latest patents focus on the use of tapinarof for treating atopic dermatitis and chronic plaque psoriasis. The first patent describes topical compositions and methods for using tapinarof to treat mild to moderate atopic dermatitis. It outlines clinical endpoints for subjects diagnosed with this condition, specifically when about 5% to 35% of body surface area is affected, and the Investigator Global Assessment (IGA) score is greater than or equal to 3. Additionally, it details endpoints for treating chronic mild to moderate plaque psoriasis, where about 3% to 20% of body surface area is affected, and the Physician Global Assessment (PGA) score is greater than or equal to 2. The second patent reiterates the use of tapinarof for chronic plaque psoriasis, emphasizing similar clinical endpoints and treatment methodologies.
Career Highlights
Kraus is currently associated with Dermavant Sciences GmbH, where he continues to develop innovative solutions for dermatological issues. His work has been instrumental in advancing the understanding and treatment of skin conditions, making a positive impact on patients' lives.
Collaborations
Kraus collaborates with various professionals in the field, including his coworker James Lee. Their combined expertise contributes to the development of effective treatments and enhances the research capabilities of their organization.
Conclusion
John E Kraus is a prominent figure in the field of dermatology, with a focus on innovative treatments for skin conditions. His contributions through patents and collaborations highlight his commitment to improving patient care and advancing medical science.